Result of General Meeting and TVR

AI SummaryClose X

ImmuPharma PLC announced that both resolutions proposed at its General Meeting were approved by shareholders, with Resolution 1 passing with 91.46% of votes in favour and Resolution 2 with 88.91% in favour. Following the meeting, the company allotted 100,000,000 Subscription Shares, 12,000,000 Value Payment Shares, 7,812,447 WRAP Retail Offer Shares, and 1,375,000 Fee Shares, totaling 121,187,447 New Ordinary Shares. Admission of these shares to AIM is expected on 8 April 2026, at which point the company's issued ordinary share capital will be 623,911,379 shares.

Disclaimer*

Companies

Immupharma (IMM)
UK 100

Latest directors dealings